E34.322 - Insulin-like growth factor-1 (IGF-1) resistance
- Applicable to Insulin-like growth factor-1 (IGF-1) resistance
- The 2025 edition of ICD10-CM E34.322 became effective on October 1, 2024.
- This is the American ICD10-CM version of E34.322 - other international versions of ICD10 E34.322 may differ.
- E34.322 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Genetic syndrome with resistance to insulin-like growth factor-1
- Insulin-like growth factor-1 receptor (IGF-1R) defect
- Post-insulin-like growth factor-1 receptor signaling defect
Billable/Specific Code
The following codes above E34.322 contain annotation back-references that may be applicable to E34.322:
- Chapter: E00-E89 - Endocrine, nutritional and metabolic diseases
- Section: E20-E35 - Disorders of other endocrine glands
- Category: E34 - Other endocrine disorders
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com